Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204316508> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W3204316508 endingPage "429" @default.
- W3204316508 startingPage "421" @default.
- W3204316508 abstract "Rhinitis is one of the most common diseases and this term is used as an umbrella diagnosis for patients with different clinical phenotypes of the disease (allergic, non-allergic, infectious, etc.). Recognizing the high socio-economic burden of the disease and complexities of choosing an optimal therapy, it is important to focus on interdisciplinary interactions, which are reflected in modern clinical guidelines created by experts from ARIA, EAACI, EPOS, as well as national and professional societies. Patients with rhinitis symptoms often self-medicate, use the advice of pharmacist, receive recommendations from general practitioners in outpatient practice, and very few patients get specialists (ENT or allergist-immunologist) advice; herefore, in many cases, optimal criteria for disease control (symptoms, quality of life, objective measurements) cannot be achieved. Currently international professional communities have developed innovative therapeutic approaches based on knowledge of the phenotypes/endotypes of rhinitis to achieve such a control. Physicians in both primary and specialized care are encouraged to use step therapy. This approach to treatment is based on the control of disease symptoms, and intranasal corticosteroids (InGCS) are considered to be the most effective anti-inflammatory drugs for long-term control of rhinitis, especially in moderate-severe/severe cases. This well-proven efficacy of InGCS and their advantages over other classes of drugs make them the first-line therapy in the treatment of allergic rhinitis (evidence level A), as well as the drugs of choice for non-allergic rhinitis and rhinosinusitis. This review discusses fluticasone propionate, one of the in-demand InGCS, which has been the cornerstone of the treatment of allergic rhinitis for many years." @default.
- W3204316508 created "2021-10-11" @default.
- W3204316508 creator A5051685363 @default.
- W3204316508 creator A5071377793 @default.
- W3204316508 creator A5079065244 @default.
- W3204316508 creator A5080844877 @default.
- W3204316508 creator A5084303710 @default.
- W3204316508 creator A5088502457 @default.
- W3204316508 date "2021-01-01" @default.
- W3204316508 modified "2023-09-25" @default.
- W3204316508 title "Intranasal fluticasone propionate in the pharmacotherapy of allergic rhinitis" @default.
- W3204316508 doi "https://doi.org/10.26442/20751753.2021.9.201059" @default.
- W3204316508 hasPublicationYear "2021" @default.
- W3204316508 type Work @default.
- W3204316508 sameAs 3204316508 @default.
- W3204316508 citedByCount "0" @default.
- W3204316508 crossrefType "journal-article" @default.
- W3204316508 hasAuthorship W3204316508A5051685363 @default.
- W3204316508 hasAuthorship W3204316508A5071377793 @default.
- W3204316508 hasAuthorship W3204316508A5079065244 @default.
- W3204316508 hasAuthorship W3204316508A5080844877 @default.
- W3204316508 hasAuthorship W3204316508A5084303710 @default.
- W3204316508 hasAuthorship W3204316508A5088502457 @default.
- W3204316508 hasBestOaLocation W32043165081 @default.
- W3204316508 hasConcept C126322002 @default.
- W3204316508 hasConcept C142724271 @default.
- W3204316508 hasConcept C159110408 @default.
- W3204316508 hasConcept C16005928 @default.
- W3204316508 hasConcept C177713679 @default.
- W3204316508 hasConcept C187212893 @default.
- W3204316508 hasConcept C203014093 @default.
- W3204316508 hasConcept C204787440 @default.
- W3204316508 hasConcept C2776042228 @default.
- W3204316508 hasConcept C2779028295 @default.
- W3204316508 hasConcept C2779134260 @default.
- W3204316508 hasConcept C2779951463 @default.
- W3204316508 hasConcept C2781212218 @default.
- W3204316508 hasConcept C500440147 @default.
- W3204316508 hasConcept C512399662 @default.
- W3204316508 hasConcept C71924100 @default.
- W3204316508 hasConceptScore W3204316508C126322002 @default.
- W3204316508 hasConceptScore W3204316508C142724271 @default.
- W3204316508 hasConceptScore W3204316508C159110408 @default.
- W3204316508 hasConceptScore W3204316508C16005928 @default.
- W3204316508 hasConceptScore W3204316508C177713679 @default.
- W3204316508 hasConceptScore W3204316508C187212893 @default.
- W3204316508 hasConceptScore W3204316508C203014093 @default.
- W3204316508 hasConceptScore W3204316508C204787440 @default.
- W3204316508 hasConceptScore W3204316508C2776042228 @default.
- W3204316508 hasConceptScore W3204316508C2779028295 @default.
- W3204316508 hasConceptScore W3204316508C2779134260 @default.
- W3204316508 hasConceptScore W3204316508C2779951463 @default.
- W3204316508 hasConceptScore W3204316508C2781212218 @default.
- W3204316508 hasConceptScore W3204316508C500440147 @default.
- W3204316508 hasConceptScore W3204316508C512399662 @default.
- W3204316508 hasConceptScore W3204316508C71924100 @default.
- W3204316508 hasIssue "9" @default.
- W3204316508 hasLocation W32043165081 @default.
- W3204316508 hasOpenAccess W3204316508 @default.
- W3204316508 hasPrimaryLocation W32043165081 @default.
- W3204316508 hasRelatedWork W1541372684 @default.
- W3204316508 hasRelatedWork W1544812087 @default.
- W3204316508 hasRelatedWork W1976099282 @default.
- W3204316508 hasRelatedWork W2028056468 @default.
- W3204316508 hasRelatedWork W2042032400 @default.
- W3204316508 hasRelatedWork W2120683684 @default.
- W3204316508 hasRelatedWork W2428016846 @default.
- W3204316508 hasRelatedWork W2473477542 @default.
- W3204316508 hasRelatedWork W3204316508 @default.
- W3204316508 hasRelatedWork W92386760 @default.
- W3204316508 hasVolume "23" @default.
- W3204316508 isParatext "false" @default.
- W3204316508 isRetracted "false" @default.
- W3204316508 magId "3204316508" @default.
- W3204316508 workType "article" @default.